JHS Svendgaard Laboratories Ltd

JHS Sven.Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JHS Svendgaard Laboratories Ltd

₹ 21.6 1.07%
22 Nov - close price
svendgaard.com BSE: 532771 NSE: JHS
About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]

Key Points

Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets

Website BSE NSE
  • Market Cap ₹ 170 Cr.
  • Current Price ₹ 21.6
  • High / Low ₹ 39.5 / 15.5
  • Stock P/E
  • Book Value ₹ 23.2
  • Dividend Yield 0.00 %
  • ROCE -1.69 %
  • ROE -2.35 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.93 times its book value
  • Company's working capital requirements have reduced from 135 days to 71.8 days

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -3.17%
  • The company has delivered a poor sales growth of -9.95% over past five years.
  • Promoter holding is low: 34.6%
  • Company has a low return on equity of -1.00% over last 3 years.
  • Earnings include an other income of Rs.4.89 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
23 19 17 19 21 22 22 16 19 14 22 24 20
22 19 18 20 23 24 25 18 19 14 21 23 21
Operating Profit 1 -0 -0 -1 -2 -2 -4 -2 0 -0 1 2 -1
OPM % 4% -1% -2% -5% -9% -10% -16% -13% 2% -0% 4% 8% -4%
1 2 2 1 3 1 -12 0 0 2 1 0 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 1 1 1 1 2 1 2 2 2 2 2
Profit before tax 1 1 0 -1 -1 -3 -17 -3 -1 1 0 0 -2
Tax % 33% 28% 2,729% 157% -13% -5% -41% -18% -26% 98% 517% 415% 398%
0 0 -4 -3 -1 -3 -10 -3 -1 0 -1 -1 -10
EPS in Rs 0.07 0.07 -0.57 -0.51 -0.14 -0.43 -1.52 -0.40 -0.09 0.00 -0.10 -0.08 -1.32
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
56 35 55 100 104 138 120 133 97 80 85 71 80
44 39 59 93 92 122 111 123 93 80 94 72 78
Operating Profit 12 -4 -4 7 12 17 8 9 4 0 -9 -1 2
OPM % 21% -11% -7% 7% 11% 12% 7% 7% 4% 0% -11% -1% 2%
12 -3 -6 -17 0 32 5 1 6 8 -7 4 5
Interest 10 14 0 0 1 1 1 1 0 0 1 0 0
Depreciation 14 15 12 10 6 7 7 7 6 6 6 6 7
Profit before tax -0 -35 -22 -22 5 41 5 2 3 2 -23 -3 -1
Tax % 2,907% -18% 0% 0% -326% 32% 31% 1% 13% 228% -24% 18%
-4 -29 -22 -22 22 28 4 2 3 -2 -18 -4 -12
EPS in Rs -1.75 -11.95 -9.19 -5.75 4.98 4.61 0.59 0.29 0.43 -0.38 -2.70 -0.52 -1.50
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: -10%
3 Years: -10%
TTM: 2%
Compounded Profit Growth
10 Years: 6%
5 Years: %
3 Years: %
TTM: -539%
Stock Price CAGR
10 Years: 11%
5 Years: 6%
3 Years: -2%
1 Year: -16%
Return on Equity
10 Years: 2%
5 Years: 1%
3 Years: -1%
Last Year: -2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 24 24 24 38 44 61 61 61 64 65 78 78 86
Reserves 50 21 78 57 86 116 119 121 127 125 96 92 96
102 54 19 2 2 2 7 3 2 2 3 5 4
41 74 33 25 23 26 33 46 21 19 39 22 22
Total Liabilities 217 173 153 123 156 205 220 230 215 211 215 197 208
135 121 108 65 65 71 69 58 59 55 65 90 90
CWIP 0 0 0 1 1 0 5 7 9 16 9 1 2
Investments 0 0 0 0 1 18 15 17 14 15 3 3 4
81 52 46 57 89 116 130 148 133 125 139 103 112
Total Assets 217 173 153 123 156 205 220 230 215 211 215 197 208

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
60 28 7 -6 -4 13 -10 15 15 -11 23 -9
-23 3 1 4 -3 -27 1 -7 -6 -1 10 -22
-40 -29 -10 4 10 14 4 -8 6 0 -1 2
Net Cash Flow -2 2 -1 2 3 0 -5 -0 16 -12 32 -28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 160 60 82 25 48 113 171 262 221 74 80 66
Inventory Days 155 122 94 53 96 59 51 19 76 104 128 177
Days Payable 478 95 106 67 125 123 134 179 126 147 221 197
Cash Conversion Cycle -163 87 70 12 19 48 88 101 171 31 -13 46
Working Capital Days -73 -548 -36 59 48 128 183 188 248 288 44 72
ROCE % 1% -11% -14% -3% 5% 9% 4% 7% 2% 1% -2% -2%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
41.77% 42.23% 42.23% 42.23% 42.23% 42.23% 42.23% 37.73% 37.73% 37.73% 37.73% 34.56%
0.04% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.29% 0.15% 1.69%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.16% 6.21% 6.05% 0.00%
58.20% 57.59% 57.77% 57.77% 57.78% 57.78% 57.78% 62.25% 53.10% 53.75% 56.05% 63.76%
No. of Shareholders 25,15524,75424,31724,30524,30823,96523,80022,79422,64826,44825,76825,994

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls